Clinical Trial Update: Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 1]

View source ↗

Summary

A Phase 1 clinical study in relapsed/refractory chronic lymphocytic leukemia sponsored by Piramal Enterprises is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) | Phase 1 | Status: SUSPENDED